Cargando…
Integrative analysis of metabolome and gut microbiota in Patients with pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumour with a poor prognosis and a high mortality rate. It is of great significance to explore sensitive or specific biomarkers for early diagnosis and prognosis. We first examined the metabolome and gut microbiota of resectable and unres...
Autores principales: | Guo, Xiaodong, Hu, Zhengjun, Rong, Shu, Xie, Guoqun, Nie, Gang, Liu, Xuan, Jin, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965132/ https://www.ncbi.nlm.nih.gov/pubmed/35371330 http://dx.doi.org/10.7150/jca.52943 |
Ejemplares similares
-
Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma
por: Cao, Ying-Ying, et al.
Publicado: (2023) -
Integrated analysis of senescence-associated genes in pancreatic ductal adenocarcinoma
por: Zhu, Zhi-gang, et al.
Publicado: (2022) -
The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma
por: Ciernikova, Sona, et al.
Publicado: (2020) -
Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma
por: Unger, Keith, et al.
Publicado: (2018) -
Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma
por: Mahajan, Ujjwal Mukund, et al.
Publicado: (2021)